064550.KQ
Bioneer Corporation
KOE · Healthcare · Biotechnology · KR
KRW 10,240.00
+2.71%Year over year
Reported trailing growth
- Revenue
- +15.9%
- EBITDA
- —
- EBIT
- +112.8%
- EPS
- -11.3%
- Free cash flow
- +82.7%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -38.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.8%
- EBITDA
- -8.1%
- EBIT
- -11.7%
- Net income
- +86.3%
- EPS
- +86.3%
- Free cash flow
- +113.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026